Praxis Precision Medicines, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 |
|---|---|---|
| Revenue | $0 | $8.6M |
| Operating income | -$326.2M | -$200.2M |
| Operating expenses | $326.2M | $208.7M |
| Cash from operations | -$249.1M | -$131.8M |
| Capital expenditure | $56,000 | $0 |
| Free cash flow | -$249.1M | -$131.8M |
| Impairments | $0 | $0 |
| Total assets | $937.9M | $483.1M |
| Total liabilities | $59.8M | $37.7M |
Shares outstanding 27.9M · Free float 69.8%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.